Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Multiple Myeloma × osimertinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Carcinoma 1

Interventions

Dexamethasone 16 daratumumab 9 Bortezomib 9 Lenalidomide 6 pomalidomide 4 carfilzomib 4 isatuximab 3 selinexor 2 Thalidomide 2 Prednisone 2 Melphalan 2 trametinib 1 talquetamab 1 montelukast 1 melflufen 1 idecabtagene vicleucel 1 darlin protein, Dictyostelium 1 dabrafenib 1 belantamab mafodotin 1 L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1 Diphenhydramine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡